Genetic risk score for Alzheimer's disease predicts brain volume differences in mid and late life in UK biobank participants

Alzheimers Dement. 2024 Mar;20(3):1978-1987. doi: 10.1002/alz.13610. Epub 2024 Jan 6.

Abstract

Introduction: We estimated the ages when associations between Alzheimer's disease (AD) genes and brain volumes begin among middle-aged and older adults.

Methods: Among 45,616 dementia-free participants aged 45-80, linear regressions tested whether genetic risk score for AD (AD-GRS) had age-dependent associations with 38 regional brain magnetic resonance imaging volumes. Models were adjusted for sex, assessment center, genetic ancestry, and intracranial volume.

Results: AD-GRS modified the estimated effect of age (per decade) on the amygdala (-0.41 mm3 [-0.42, -0.40]); hippocampus (-0.45 mm3 [-0.45, -0.44]), nucleus accumbens (-0.55 mm3 [-0.56, -0.54]), thalamus (-0.38 mm3 [-0.39, -0.37]), and medial orbitofrontal cortex (-0.23 mm3 [-0.24, -0.22]). Trends began by age 45 for the nucleus accumbens and thalamus, 48 for the hippocampus, 51 for the amygdala, and 53 for the medial orbitofrontal cortex. An AD-GRS excluding apolipoprotein E (APOE) was additionally associated with entorhinal and middle temporal cortices.

Discussion: APOE and other genes that increase AD risk predict lower hippocampal and other brain volumes by middle age.

Keywords: Alzheimer's disease; age; dementia; genetic risk score; magnetic resonance imaging (MRI); neurodegeneration.

MeSH terms

  • Aged
  • Alzheimer Disease* / complications
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / genetics
  • Apolipoproteins E / genetics
  • Biological Specimen Banks
  • Brain / diagnostic imaging
  • Brain / pathology
  • Genetic Risk Score
  • Hippocampus / diagnostic imaging
  • Hippocampus / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • UK Biobank

Substances

  • Apolipoproteins E